Valneva plans to present at healthcare investor conferences
VALN•Valneva plans to present at four healthcare investor conferences in Paris, Boston, New York and London from October 15 to November 16, 2026. Discussions will focus on its Pfizer-partnered Lyme disease vaccine candidate, with regulatory decisions expected within 12 months.
1. Conference schedule
Valneva will present virtually at the Portzamparc BNP Paribas Séminaire Biotech & Santé in Paris on October 15, 2026. It also plans fireside chats and investor meetings at conferences in Boston on November 9, New York on November 10 and London on November 16.
2. Vaccine outlook
Discussions will focus on the regulatory outlook for Valneva’s Pfizer-partnered Lyme disease vaccine candidate, with decisions expected within 12 months.
